HIV and AIDS Trial, Recruiting (NCT07509827)

HIV and AIDS Trial, Recruiting NCT07509827 Sponsor: Institute of HIV Research and Innovation Foundation, Thailand Condition: HIV and AIDS

Printed from Voxsanity (voxsanity.com.au) — NCT07509827 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Hiv Aids

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Be between 18 and 29 years old
Have been assigned male at birth
Self-identify as a transgender woman or somewhere on the female spectrum
Have tested negative for HIV (confirmed by a lab test)
Have had sex without a condom recently
Be able to understand Thai
Not currently be taking PrEP, or be taking it inconsistently (3 or fewer pills per week)

Who may not be able to join:

Have a serious cognitive or mental health condition that could affect your ability to give informed consent
Currently be experiencing thoughts of suicide or have a major mental illness
Have a medical reason why taking PrEP would not be safe for you (confirm with trial site)
Already be taking part in another research study focused on HIV prevention

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 7 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Nittaya Phanuphak, MD,PhD., INSTITUTE OF HIV RESEARCH AND INNOVATION FOUNDATION

Phone: 6681 825 3544

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07509827

Sponsor: Institute of HIV Research and Innovation Foundation, Thailand

Phase: Not Applicable

Status: Recruiting

Condition: HIV and AIDS

Trial contact: 6681 825 3544

More information: https://clinicaltrials.gov/study/NCT07509827

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Be between 18 and 29 years old
Have been assigned male at birth
Self-identify as a transgender woman or somewhere on the female spectrum
Have tested negative for HIV (confirmed by a lab test)
Have had sex without a condom recently
Be able to understand Thai
Not currently be taking PrEP, or be taking it inconsistently (3 or fewer pills per week)

Who may not be able to join:

Have a serious cognitive or mental health condition that could affect your ability to give informed consent
Currently be experiencing thoughts of suicide or have a major mental illness
Have a medical reason why taking PrEP would not be safe for you (confirm with trial site)
Already be taking part in another research study focused on HIV prevention

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 7 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Institute of HIV Research and Innovation Foundation, Thailand

Registry

ClinicalTrials.gov

Start date

1 August 2024

Est. completion

31 July 2027

Where this trial is recruiting

🇹🇭 Thailand

Primary endpoints

HIV-related stigma score; PrEP uptake; PrEP adherence; HIV testing uptake

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov